Abstract
The catecholamine hormone norepinephrine (N.E.) lies at the center of most recent developments in the chemotherapy of hypertension. Drugs such as reserpine, guanethidine, a-methyldopa, and the monamine-oxidase (M.A.O.) inhibitors, by varying mechanisms, interfere with processes which govern the availability of this sympathetic nerve transmitter to receptor sites (e.g. blood vessels) and thereby lower the blood pressure. Although it has not been shown that N.E. plays a primary role in the pathogenesis of essential hypertension, this hormone and its N-methylated derivative, epinephrine, are responsible for the occurrence of the hypertensive syndrome in patients with pheochromocytoma. Chemical assay of these catecholamines and their major metabolites in urine provides the most definitive means of diagnosing this condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abboud, F. M., and J. W. Eckstein: Circulation 29, 219 (1964).
— Burn, J. H., and M. J. Rand: J. Physiol. 144, 314 (1958).
— Brodie, B. B.: Circulation 28, 970 (1963).
— Cablsson, A., E. Rosengren, A. Bebtleb, and J. Nilsson: In: Psychotropic Drugs. Ed. by S. Gabattini and V. Ghetti. Elsevier Publishing Co., Amsterdam, 1957, p. 363.
— Chang, C. C., E. Costa, and B. B. Bbodie: J. Pharmacol. Exper. Therap. 147, 303 (1965).
— Chedsey, C. A., E. Braunwald, A. G. Mobbow, and D. T. Mason: N. England J. Med. 269, 653 (1963).
— Cohn, J. N., T. E. Liptak, and E. D. Fbeis: Circulation Res. 12, 298 (1963).
— Day, M. D., and M. J. Rand: Brit. J. Pharmacol. 22, 72 (1964).
— Dolleby, C. T., M. Habington, and J. V. Hodge: Brit. Heart J. 25, 670 (1963).
— Engelman, K., and A. Sjoebdsma: Ann. Int. Med. 61, 229 (1964a).
— Engelman, K., and A. Sjoebdsma: J. Amer. Med. Ass. 189, 81 (1964b).
— Gale, E. F.: Biochem. J. 34, 846 (1940).
— Gdllespie, L., J. A. Oates, J. R. Cbout, and A. Sjoebdsma: Circulation 25, 281 (1962).
— Hess, S. M., R. H. Connamacher, M. Ozaki, and S. Udenfbiend: J. Pharmacol. Exper. Therap. 134, 129 (1963).
— Horwttz, D.: In: Cardiovascular Drug Therapy. Ed. by A. N. Brest and J. H. Moyer. Grune and Stratton, New York, 1965, p. 29.
— Kopin, I. J., J. E. Fischer, J. M. Musacchio, W. D. Horst, and V. Weise: J. Pharmacol. Exper. Therap. 147, 186 (1965).
— Leading Article: Lancet 1965/I, 945.
— Levitt, M., S. Spector, A. Sjoerdsma, and S. Udenfriend: J. Pharmacol. Exper. Therap. 148, 1 (1965).
— Lovenberg, W., H. Weissbach, and S. Udenfriend: J. Biol. Chem. 237, 89 (1962).
— McCujrdy, R. L., A. J. Prange, M. A. Lipton, and C. M. Cochrane: Proc. Soc. Exper. Biol. Med. 116, 1159 (1964).
— Neussle, W. F., F. C. Norman, and H. E. Miller: J. Amer. Med. Ass. 192, 726 (1965).
— Nicodijevic, B., C. R. Creveling, and S. Udenfriend: J. Pharmacol. Exper. Therap. 140, 224 (1963).
— Oates, J. A., L. Gillespie, S. Udenfriend, and A. Sjoerdsma: Science 131, 1890(1960).
— Pettinger, W. A., D. Horwttz, S. Spector, and A. Sjoerdsma: Nature 200, 1107 (1963).
— Pettinger, W. A., S. Spector, D. Horwttz, and A. Sjoerdsma: Proc. Soc. Exper. Biol. Med. 118, 988 (1965).
— Potter, L., and J. Axelrod: J. Pharmacol. Exper. Therap. 140, 199 (1963).
— Sjoerdsma, A.: Circulation Res. 9, 734 (1961).
— Sjoerdsma, A., A. Vendsalu, and K. Engelman: Circulation 28, 492 (1963).
— Sjoerdsma, A., and W. von Studnitz: Brit. J. Pharmacol. 20, 278 (1963).
— Spector, S., A. Sjoerdsma, and S. Udenfriend: J. Pharmacol. Exper. Therap. 147, 86 (1965).
— Spector, S., A. Sjoerdsma, P. Zaltzman-Nirenberg, M. Levitt, and S. Udenfriend: Science 139, 1299 (1963).
— Stjärne, L.: Acta physiol. Scand. 62, Suppl. 228 (1964).
— Symposium on Catecholamines: Pharmacol. Rev. 11, 317 (1959).
Editor information
Rights and permissions
Copyright information
© 1966 Springer-Verlag · Berlin · Heidelberg
About this chapter
Cite this chapter
Sjoerdsma, A. (1966). Some biochemical aspects of treatment and diagnosis of hypertension. In: Gross, F. (eds) Antihypertensive Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-50238-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-50238-5_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-50240-8
Online ISBN: 978-3-642-50238-5
eBook Packages: Springer Book Archive